Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Streptase
Active Ingredient: Streptokinase 1,500,000IU
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited
Manufacturer: Aventis Behring GmbH, Marburg, Germany
Product: Streptase
Active Ingredient: Streptokinase 250,000IU
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited
Manufacturer: Aventis Behring GmbH, Marburg, Germany
Product: Streptase
Active Ingredient: Streptokinase 750,000IU
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited
Manufacturer: Aventis Behring GmbH, Marburg, Germany
Product: Symbicort 200/6 Turbuhaler
Active Ingredients: Budesonide 160Ág/dose equivalent to 200Ág metered doseFormoterol fumarate 4.5Ág/dose equivalent to 6Ág metered dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Sodertalje, Sweden
Product: Symbicort 400/12 Turbuhaler
Active Ingredients: Budesonide 400Ág equivalent to 320Ág delivered doseFormoterol fumarate 12Ág equivalent to 9Ág eformoterol fumarate per delivered dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Sodertalje, Sweden
Product: Zithromax
Active Ingredient: Azithromycin 40mg/g
Dosage Form: Powder for oral suspension
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Italia Srl, Borgo San Michele, Latina, Italy Pfizer Limited, Sandwich, Kent, England
Dated this 6th day of February 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).